カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のエタネルセプト薬物市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Etanercept Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19302）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19302
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：79
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のエタネルセプト薬物市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

エタネルセプト薬物市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のエタネルセプト薬物の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

エタネルセプト薬物市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ブランド医薬品、バイオシミラー

用途別セグメントは次のように区分されます。
・関節リウマチ、若年性特発性関節炎、乾癬性関節炎、強直性脊椎炎、その他

世界のエタネルセプト薬物市場の主要な市場プレーヤーは以下のとおりです。
・Amgen、Pfizer、3SBIO、Celgen Biopharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、エタネルセプト薬物製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なエタネルセプト薬物メーカーの企業概要、2019年～2022年までのエタネルセプト薬物の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なエタネルセプト薬物メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別エタネルセプト薬物の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのエタネルセプト薬物の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのエタネルセプト薬物市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびエタネルセプト薬物の産業チェーンを掲載しています。
・第13、14、15章では、エタネルセプト薬物の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- エタネルセプト薬物の概要
- 種類別分析（2017年vs2021年vs2028年）：ブランド医薬品、バイオシミラー
- 用途別分析（2017年vs2021年vs2028年）：関節リウマチ、若年性特発性関節炎、乾癬性関節炎、強直性脊椎炎、その他
- 世界のエタネルセプト薬物市場規模・予測
- 世界のエタネルセプト薬物生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Amgen、Pfizer、3SBIO、Celgen Biopharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ブランド医薬品、バイオシミラー
・用途別分析2017年-2028年：関節リウマチ、若年性特発性関節炎、乾癬性関節炎、強直性脊椎炎、その他
・エタネルセプト薬物の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・エタネルセプト薬物のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・エタネルセプト薬物のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・エタネルセプト薬物の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・エタネルセプト薬物の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Etanercept Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Etanercept Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Rheumatoid Arthritis accounting for % of the Etanercept Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Brands Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Etanercept Drugs include Amgen, Pfizer, 3SBIO, Celgen Biopharma, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Etanercept Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Brands Drugs
Biosimilar Drugs
Market segment by Application can be divided into
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Other
The key market players for global Etanercept Drugs market are listed below:
Amgen
Pfizer
3SBIO
Celgen Biopharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Etanercept Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Etanercept Drugs, with price, sales, revenue and global market share of Etanercept Drugs from 2019 to 2022.
Chapter 3, the Etanercept Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Etanercept Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Etanercept Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Etanercept Drugs.
Chapter 13, 14, and 15, to describe Etanercept Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Etanercept Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Etanercept Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Brands Drugs
1.2.3 Biosimilar Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Etanercept Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Rheumatoid Arthritis
1.3.3 Juvenile Idiopathic Arthritis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Other
1.4 Global Etanercept Drugs Market Size & Forecast
1.4.1 Global Etanercept Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Etanercept Drugs Sales in Volume (2017-2028)
1.4.3 Global Etanercept Drugs Price (2017-2028)
1.5 Global Etanercept Drugs Production Capacity Analysis
1.5.1 Global Etanercept Drugs Total Production Capacity (2017-2028)
1.5.2 Global Etanercept Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Etanercept Drugs Market Drivers
1.6.2 Etanercept Drugs Market Restraints
1.6.3 Etanercept Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Etanercept Drugs Product and Services
2.1.4 Amgen Etanercept Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Etanercept Drugs Product and Services
2.2.4 Pfizer Etanercept Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 3SBIO
2.3.1 3SBIO Details
2.3.2 3SBIO Major Business
2.3.3 3SBIO Etanercept Drugs Product and Services
2.3.4 3SBIO Etanercept Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Celgen Biopharma
2.4.1 Celgen Biopharma Details
2.4.2 Celgen Biopharma Major Business
2.4.3 Celgen Biopharma Etanercept Drugs Product and Services
2.4.4 Celgen Biopharma Etanercept Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Etanercept Drugs Breakdown Data by Manufacturer
3.1 Global Etanercept Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Etanercept Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Etanercept Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Etanercept Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Etanercept Drugs Manufacturer Market Share in 2021
3.5 Global Etanercept Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Etanercept Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Etanercept Drugs Market Size by Region
4.1.1 Global Etanercept Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Etanercept Drugs Revenue by Region (2017-2028)
4.2 North America Etanercept Drugs Revenue (2017-2028)
4.3 Europe Etanercept Drugs Revenue (2017-2028)
4.4 Asia-Pacific Etanercept Drugs Revenue (2017-2028)
4.5 South America Etanercept Drugs Revenue (2017-2028)
4.6 Middle East and Africa Etanercept Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Etanercept Drugs Sales in Volume by Type (2017-2028)
5.2 Global Etanercept Drugs Revenue by Type (2017-2028)
5.3 Global Etanercept Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Etanercept Drugs Sales in Volume by Application (2017-2028)
6.2 Global Etanercept Drugs Revenue by Application (2017-2028)
6.3 Global Etanercept Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Etanercept Drugs Sales by Type (2017-2028)
7.2 North America Etanercept Drugs Sales by Application (2017-2028)
7.3 North America Etanercept Drugs Market Size by Country
7.3.1 North America Etanercept Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Etanercept Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Etanercept Drugs Sales by Type (2017-2028)
8.2 Europe Etanercept Drugs Sales by Application (2017-2028)
8.3 Europe Etanercept Drugs Market Size by Country
8.3.1 Europe Etanercept Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Etanercept Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Etanercept Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Etanercept Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Etanercept Drugs Market Size by Region
9.3.1 Asia-Pacific Etanercept Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Etanercept Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Etanercept Drugs Sales by Type (2017-2028)
10.2 South America Etanercept Drugs Sales by Application (2017-2028)
10.3 South America Etanercept Drugs Market Size by Country
10.3.1 South America Etanercept Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Etanercept Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Etanercept Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Etanercept Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Etanercept Drugs Market Size by Country
11.3.1 Middle East & Africa Etanercept Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Etanercept Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Etanercept Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Etanercept Drugs
12.3 Etanercept Drugs Production Process
12.4 Etanercept Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Etanercept Drugs Typical Distributors
13.3 Etanercept Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Etanercept Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Etanercept Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Etanercept Drugs Product and Services
Table 6. Amgen Etanercept Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Etanercept Drugs Product and Services
Table 10. Pfizer Etanercept Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. 3SBIO Basic Information, Manufacturing Base and Competitors
Table 12. 3SBIO Major Business
Table 13. 3SBIO Etanercept Drugs Product and Services
Table 14. 3SBIO Etanercept Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Celgen Biopharma Basic Information, Manufacturing Base and Competitors
Table 16. Celgen Biopharma Major Business
Table 17. Celgen Biopharma Etanercept Drugs Product and Services
Table 18. Celgen Biopharma Etanercept Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global Etanercept Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 20. Global Etanercept Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in Etanercept Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global Etanercept Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Etanercept Drugs Production Site of Key Manufacturer
Table 24. Etanercept Drugs New Entrant and Capacity Expansion Plans
Table 25. Etanercept Drugs Mergers & Acquisitions in the Past Five Years
Table 26. Global Etanercept Drugs Sales by Region (2017-2022) & (K Units)
Table 27. Global Etanercept Drugs Sales by Region (2023-2028) & (K Units)
Table 28. Global Etanercept Drugs Revenue by Region (2017-2022) & (USD Million)
Table 29. Global Etanercept Drugs Revenue by Region (2023-2028) & (USD Million)
Table 30. Global Etanercept Drugs Sales by Type (2017-2022) & (K Units)
Table 31. Global Etanercept Drugs Sales by Type (2023-2028) & (K Units)
Table 32. Global Etanercept Drugs Revenue by Type (2017-2022) & (USD Million)
Table 33. Global Etanercept Drugs Revenue by Type (2023-2028) & (USD Million)
Table 34. Global Etanercept Drugs Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Etanercept Drugs Price by Type (2023-2028) & (US$/Unit)
Table 36. Global Etanercept Drugs Sales by Application (2017-2022) & (K Units)
Table 37. Global Etanercept Drugs Sales by Application (2023-2028) & (K Units)
Table 38. Global Etanercept Drugs Revenue by Application (2017-2022) & (USD Million)
Table 39. Global Etanercept Drugs Revenue by Application (2023-2028) & (USD Million)
Table 40. Global Etanercept Drugs Price by Application (2017-2022) & (US$/Unit)
Table 41. Global Etanercept Drugs Price by Application (2023-2028) & (US$/Unit)
Table 42. North America Etanercept Drugs Sales by Country (2017-2022) & (K Units)
Table 43. North America Etanercept Drugs Sales by Country (2023-2028) & (K Units)
Table 44. North America Etanercept Drugs Revenue by Country (2017-2022) & (USD Million)
Table 45. North America Etanercept Drugs Revenue by Country (2023-2028) & (USD Million)
Table 46. North America Etanercept Drugs Sales by Type (2017-2022) & (K Units)
Table 47. North America Etanercept Drugs Sales by Type (2023-2028) & (K Units)
Table 48. North America Etanercept Drugs Sales by Application (2017-2022) & (K Units)
Table 49. North America Etanercept Drugs Sales by Application (2023-2028) & (K Units)
Table 50. Europe Etanercept Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Etanercept Drugs Sales by Country (2023-2028) & (K Units)
Table 52. Europe Etanercept Drugs Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe Etanercept Drugs Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe Etanercept Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Etanercept Drugs Sales by Type (2023-2028) & (K Units)
Table 56. Europe Etanercept Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Etanercept Drugs Sales by Application (2023-2028) & (K Units)
Table 58. Asia-Pacific Etanercept Drugs Sales by Region (2017-2022) & (K Units)
Table 59. Asia-Pacific Etanercept Drugs Sales by Region (2023-2028) & (K Units)
Table 60. Asia-Pacific Etanercept Drugs Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific Etanercept Drugs Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific Etanercept Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Asia-Pacific Etanercept Drugs Sales by Type (2023-2028) & (K Units)
Table 64. Asia-Pacific Etanercept Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Asia-Pacific Etanercept Drugs Sales by Application (2023-2028) & (K Units)
Table 66. South America Etanercept Drugs Sales by Country (2017-2022) & (K Units)
Table 67. South America Etanercept Drugs Sales by Country (2023-2028) & (K Units)
Table 68. South America Etanercept Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. South America Etanercept Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. South America Etanercept Drugs Sales by Type (2017-2022) & (K Units)
Table 71. South America Etanercept Drugs Sales by Type (2023-2028) & (K Units)
Table 72. South America Etanercept Drugs Sales by Application (2017-2022) & (K Units)
Table 73. South America Etanercept Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Middle East & Africa Etanercept Drugs Sales by Region (2017-2022) & (K Units)
Table 75. Middle East & Africa Etanercept Drugs Sales by Region (2023-2028) & (K Units)
Table 76. Middle East & Africa Etanercept Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa Etanercept Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa Etanercept Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Middle East & Africa Etanercept Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Middle East & Africa Etanercept Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Middle East & Africa Etanercept Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Etanercept Drugs Raw Material
Table 83. Key Manufacturers of Etanercept Drugs Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Etanercept Drugs Typical Distributors
Table 87. Etanercept Drugs Typical Customers
List of Figures
Figure 1. Etanercept Drugs Picture
Figure 2. Global Etanercept Drugs Revenue Market Share by Type in 2021
Figure 3. Brands Drugs
Figure 4. Biosimilar Drugs
Figure 5. Global Etanercept Drugs Revenue Market Share by Application in 2021
Figure 6. Rheumatoid Arthritis
Figure 7. Juvenile Idiopathic Arthritis
Figure 8. Psoriatic Arthritis
Figure 9. Ankylosing Spondylitis
Figure 10. Other
Figure 11. Global Etanercept Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Etanercept Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Etanercept Drugs Sales (2017-2028) & (K Units)
Figure 14. Global Etanercept Drugs Price (2017-2028) & (US$/Unit)
Figure 15. Global Etanercept Drugs Production Capacity (2017-2028) & (K Units)
Figure 16. Global Etanercept Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Etanercept Drugs Market Drivers
Figure 18. Etanercept Drugs Market Restraints
Figure 19. Etanercept Drugs Market Trends
Figure 20. Global Etanercept Drugs Sales Market Share by Manufacturer in 2021
Figure 21. Global Etanercept Drugs Revenue Market Share by Manufacturer in 2021
Figure 22. Etanercept Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Etanercept Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Etanercept Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Etanercept Drugs Sales Market Share by Region (2017-2028)
Figure 26. Global Etanercept Drugs Revenue Market Share by Region (2017-2028)
Figure 27. North America Etanercept Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Europe Etanercept Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Etanercept Drugs Revenue (2017-2028) & (USD Million)
Figure 30. South America Etanercept Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Etanercept Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Global Etanercept Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Etanercept Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Etanercept Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Etanercept Drugs Sales Market Share by Application (2017-2028)
Figure 36. Global Etanercept Drugs Revenue Market Share by Application (2017-2028)
Figure 37. Global Etanercept Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Etanercept Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America Etanercept Drugs Sales Market Share by Application (2017-2028)
Figure 40. North America Etanercept Drugs Sales Market Share by Country (2017-2028)
Figure 41. North America Etanercept Drugs Revenue Market Share by Country (2017-2028)
Figure 42. United States Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Etanercept Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe Etanercept Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Etanercept Drugs Sales Market Share by Country (2017-2028)
Figure 48. Europe Etanercept Drugs Revenue Market Share by Country (2017-2028)
Figure 49. Germany Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Etanercept Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Etanercept Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Etanercept Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Etanercept Drugs Revenue Market Share by Region (2017-2028)
Figure 58. China Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Etanercept Drugs Sales Market Share by Type (2017-2028)
Figure 65. South America Etanercept Drugs Sales Market Share by Application (2017-2028)
Figure 66. South America Etanercept Drugs Sales Market Share by Country (2017-2028)
Figure 67. South America Etanercept Drugs Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Etanercept Drugs Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Etanercept Drugs Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Etanercept Drugs Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Etanercept Drugs Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Etanercept Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Etanercept Drugs in 2021
Figure 79. Manufacturing Process Analysis of Etanercept Drugs
Figure 80. Etanercept Drugs Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
  • 世界のエクセナチド薬物市場2022年：市場規模予測（～2028年）
  • 世界のペガスパルガーゼ薬物市場2022年：市場規模予測（～2028年）
  • 世界のリロナセプト薬物市場2022年：市場規模予測（～2028年）
  • 世界のブリナツモマブ治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19302 )"世界のエタネルセプト薬物市場2022年：市場規模予測（～2028年）" (英文：Global Etanercept Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。